Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- befree-20150227 importedOn "2015-02-27" NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_assertion wasGeneratedBy ECO_0000203 NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_assertion wasDerivedFrom befree-20150227 NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_assertion SIO_000772 19864236 NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_assertion evidence source_evidence_literature NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.
- NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620366.RA2YihuQV1qAzBAxZYu0oD1kepdXBhbTd54hHE1bQb16E130_provenance.